penicillin v has been researched along with clarithromycin in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (33.33) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Amaral, K; Dzink-Fox, J; Fischer, E; Goldovitz, J; Manni, K; Neckermann, G; Osborne, CS; Pecanka, R; Ryder, NS; Yu, D | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Denny, FW | 1 |
| Schrock, CG | 1 |
| Levenstein, JH | 1 |
| Bachand, RT | 1 |
| Christensen, S; Mummaw, N; Stein, GE | 1 |
| Chartrand, S; Hubbard, WC; Jacobs, R; Poole, JM; Sheaffer, CI; Still, JG | 1 |
| Hakkarinen, WD | 1 |
| Luger, SW | 1 |
| Chauvin, JP; Filipecki, J; Goldfarb, G; Lethuaire, D; Portier, H; Weber, P | 1 |
| Busman, T; Dzyublyk, O; Notario, G; Takker, U | 1 |
| Aoudi, H; Bairamis, T; Kafetzis, DA; Liapi, G; Mathioudakis, J; Paraskakis, I; Tsolia, M | 1 |
| Hersh, EV | 1 |
| Leroy, B; Norrby, SR; Quinn, J; Rangaraju, M | 1 |
| Barker, TA; Clarke, B; Denley, H; Grötte, GJ; Kadir, IS | 1 |
| Applebaum, PC; Beratis, NG; Bozdogan, B; Ednie, LM; Grivea, IN; Katopodis, GD; Kritikou, DI; Syrogiannopoulos, GA | 1 |
| Hviid, A; Pasternak, B; Svanström, H | 1 |
| Cardona, AF; Reveiz, L | 1 |
| Andersen, JT; Broedbaek, K; Cejvanovic, V; Hansen, LK; Henriksen, T; Jimenez-Solem, E; Kjaer, LK; Larsen, EL; Lykkesfeldt, J; Pedersen, MT; Petersen, M; Popik, SD; Poulsen, HE; Torp-Pedersen, C; Weimann, A | 1 |
2 review(s) available for penicillin v and clarithromycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antibiotics for acute laryngitis in adults.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Clarithromycin; Depsipeptides; Erythromycin; Fusarium; Humans; Laryngitis; Penicillin V; Randomized Controlled Trials as Topic | 2015 |
11 trial(s) available for penicillin v and clarithromycin
| Article | Year |
|---|---|
Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis.
Topics: Adolescent; Adult; Child; Clarithromycin; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Single-Blind Method; Streptococcal Infections; Streptococcus pyogenes | 1992 |
Clarithromycin versus penicillin in the treatment of streptococcal pharyngitis.
Topics: Adolescent; Adult; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Remission Induction; Streptococcal Infections; Streptococcus pyogenes | 1991 |
A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitis.
Topics: Adolescent; Adult; Ambulatory Care; Child; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1991 |
Comparative study of clarithromycin and penicillin V in the treatment of streptococcal pharyngitis.
Topics: Adolescent; Adult; Child; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1991 |
Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies.
Topics: Child; Child, Preschool; Clarithromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Penicillin V; Pharyngitis; Single-Blind Method; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 1993 |
Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Bacterial Agents; Chi-Square Distribution; Clarithromycin; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Male; Penicillin V; Penicillins; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 2002 |
Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Bacterial Agents; Child; Clarithromycin; Delayed-Action Preparations; Double-Blind Method; Drug Resistance, Bacterial; Humans; Middle Aged; Patient Compliance; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2003 |
Failure to eradicate Group A beta-haemolytic streptococci (GABHS) from the upper respiratory tract after antibiotic treatment.
Topics: Anti-Bacterial Agents; Child; Clarithromycin; Drug Administration Schedule; Female; Humans; Male; Microbial Sensitivity Tests; Penicillin V; Pharyngitis; Prospective Studies; Safety; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 2004 |
Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Female; Humans; Infant; Ketolides; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2004 |
Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
Topics: Acute Disease; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Penicillin V; Pharyngitis; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Treatment Outcome | 2004 |
Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Anti-Bacterial Agents; Biomarkers; Clarithromycin; Deoxyguanosine; DNA; Guanosine; Healthy Volunteers; Humans; Lipid Peroxidation; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Penicillin V; Placebos; Reactive Oxygen Species; RNA; Trimethoprim; Young Adult | 2017 |
11 other study(ies) available for penicillin v and clarithromycin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.
Topics: Acetamides; Amidohydrolases; Animals; Anti-Infective Agents; Female; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Peptides; Pneumonia; Staphylococcus aureus; Streptococcus pneumoniae; Thigh | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Current management of streptococcal pharyngitis.
Topics: Clarithromycin; Drug Resistance, Microbial; Humans; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1992 |
Clarithromycin vs penicillin.
Topics: Child; Clarithromycin; Humans; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Clarithromycin vs penicillin.
Topics: Clarithromycin; Fees, Pharmaceutical; Humans; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Comment on: comparison of 5 days of ER clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis.
Topics: Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP4A; Drug Administration Schedule; Drug Interactions; Humans; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 2004 |
Recurrent acute rheumatic fever: a forgotten diagnosis?
Topics: Acute Disease; Adult; Amoxicillin; Anti-Inflammatory Agents; Aortic Valve; Aortic Valve Insufficiency; Arthralgia; Bangladesh; Clarithromycin; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Emigration and Immigration; Endocarditis, Bacterial; England; Female; Fever; Gentamicins; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Penicillin G; Penicillin V; Pericarditis; Pharyngitis; Prednisone; Recurrence; Rheumatic Fever; Rheumatic Heart Disease; Rifampin; Unnecessary Procedures; Vancomycin | 2004 |
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Cohort Studies; Cytochrome P-450 CYP3A Inhibitors; Denmark; Enzyme Inhibitors; Female; Humans; Logistic Models; Male; Middle Aged; Penicillin V; Propensity Score; Registries; Roxithromycin; Sex Factors | 2014 |